Stem Cell Therapies Laboratory, Queensland University of Technology (QUT), Institute of Health and Biomedical Innovation (IHBI), Translational Research Institute (TRI), Brisbane, Australia.
Science and Engineering Faculty (SEF), Translational Research Institute (TRI), Brisbane, Australia.
Cell Tissue Res. 2018 Dec;374(3):541-553. doi: 10.1007/s00441-018-2894-y. Epub 2018 Aug 22.
Bone marrow-derived mesenchymal stem/stromal cells (BMSC) may facilitate bone repair through secretion of factors that stimulate endogenous repair processes or through direct contribution to new bone through differentiation into osteoblast-like cells. BMSC microtissue culture and differentiation has been widely explored recently, with high-throughput platforms making large-scale manufacture of microtissues increasingly feasible. Bone-like BMSC microtissues could offer an elegant method to enhance bone repair, especially in small-volume non-union defects, where small diameter microtissues could be delivered orthoscopically. Using a high-throughput microwell platform, our data demonstrate that (1) BMSC in 3D microtissue culture result in tissue compaction, rather than growth, (2) not all mineralised bone-like matrix is incorporated in the bulk microtissue mass and (3) a significant amount of lipid vacuole formation is observed in BMSC microtissues exposed to BMP-2. These factors should be considered when optimising BMSC osteogenesis in microtissues or developing BMSC microtissue-based therapeutic delivery processes.
骨髓间充质干细胞(BMSC)可能通过分泌刺激内源性修复过程的因子,或通过分化为成骨样细胞直接促进新骨形成,从而促进骨修复。最近,BMSC 微组织培养和分化得到了广泛的探索,高通量平台使得大规模制造微组织变得越来越可行。类骨 BMSC 微组织为增强骨修复提供了一种优雅的方法,特别是在小体积非愈合缺陷中,小直径微组织可以通过内窥镜进行输送。使用高通量微井平台,我们的数据表明:(1)BMSC 在 3D 微组织培养中导致组织压实,而不是生长;(2)并非所有矿化的类骨基质都包含在大块微组织质量中;(3)在 BMP-2 作用下,BMSC 微组织中观察到大量脂滴形成。在优化微组织中 BMSC 成骨或开发基于 BMSC 微组织的治疗性输送过程时,应考虑这些因素。